Sequence Similarity Clusters for the Entities in PDB 1RZJ

Entity #1 | Chains: G
ENVELOPE GLYCOPROTEIN GP120 protein, length: 321 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 3 28261
95 % 11 15 4057 Flexibility: Medium
Max RMSD: 16.1, Avg RMSD: 5.5
PDBFlex
90 % 11 15 4109
70 % 66 180 135
50 % 66 180 164
40 % 66 180 177
30 % 66 183 194
Entity #2 | Chains: C
T-CELL SURFACE GLYCOPROTEIN CD4 protein, length: 185 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 16 38 862
95 % 17 43 883 Flexibility: Low
Max RMSD: 2.4, Avg RMSD: 1.2
PDBFlex
90 % 17 43 917
70 % 17 43 943
50 % 17 43 989
40 % 17 43 1005
30 % 17 43 996
Entity #3 | Chains: L
ANTIBODY 17B, LIGHT CHAIN protein, length: 214 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 13 21 1536
95 % 16 34 1092 Flexibility: Low
Max RMSD: 5.3, Avg RMSD: 1.1
PDBFlex
90 % 401 778 2
70 % 1292 2538 1
50 % 2648 5152 1
40 % 3030 5806 1
30 % 3718 7240 1
Entity #4 | Chains: H
ANTIBODY 17B, HEAVY CHAIN protein, length: 229 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 12 24 1335
95 % 13 25 1466 Flexibility: Low
Max RMSD: 3.9, Avg RMSD: 1.0
PDBFlex
90 % 13 25 1490
70 % 1284 2497 2
50 % 2649 5152 1
40 % 3031 5806 1
30 % 3719 7240 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
3 4XCF 1 L 4E10 Fab light chain 9606
4 5X08 2 L Fab 4E10 Light chain 9606
5 4XAW 1 L 4E10 Fab light chain 9606
6 5UCB 2 L Fab Light Chain 9606
7 2VXV 2 L HUMAN IGG ABT-325 9606
8 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
9 5I8C 2 B VRC34.01 Fab light chain 9606
10 5WK2 1 L M116 LIGHT CHAIN 9606
11 3PP4 2 L GA101 Fab light chain 10090
12 4PTU 1 A Antibody pn132p2C05, light chain 9606
13 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
14 4XC3 1 L 4E10 Fab light chain 9606
15 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
16 5VSI 2 L CH1/Ckappa Fab light chain 9606
17 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
18 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
19 4NWU 2 L APE1551 Ab Fab light chain 9606
20 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
21 5EWI 2 L VRC38.01 Light Chain 9606
22 5E2W 1 L AT8 LIGHT CHAIN 10090
23 5E2V 1 L AT8 LIGHT CHAIN 10090
24 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
25 5OB5 3 L fAb Light chain 9606
26 3QQ9 1 C, L 101F LIGHT CHAIN 10090
27 5I1K 1 L FAB LIGHT CHAIN 9606
28 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
29 5V7U 1 L CBTAU-22.1 Fab light chain 9606
30 5UEA 3 B, L Fab Light Chain 9606
31 5NMV 1 L Fab light chain 10088
32 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
33 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
34 3QRG 1 L Fab light chain 9606
35 3NCJ 1 L Fab15 Mut8 light chain 9606
36 5W05 1 L M59 FAB LIGHT CHAIN 10090
37 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
38 1UM5 1 L Antibody 21H3 L chain 10090
39 4NWT 1 L APE1531 Ab Fab light chain 9606
40 3NA9 1 L Fab15 light chain 9606
41 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
42 4LRI 1 A, B MSL-109 Light Chain 9606
43 4JN2 1 A, L anti dabigatran Fab 10090
44 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
45 5U6A 1 A Light Chain 9606
46 4HHA 1 A Fab KE5 Fab fragment KE5 9606
47 5UEK 3 L Fab 12E Light Chain 9606
48 3NAA 1 L Fab15 Mut5 light chain 9606
49 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
50 5IK3 2 B, D 1E03 Fab fragment light chain 9606
51 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
52 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
53 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
54 5IT2 2 L light chain 9606
55 6BQB 1 L MGG4 Fab light chain 9606
56 4PUB 2 L DX-2930 LIGHT CHAIN 9606
57 6B14 2 L Light chain of Fab BL3-6S97N 10090
58 5VKD 3 L Fab light chain 9606
59 5XHG 1 A, C polypeptide(L) 562
60 3OAZ 2 K, L Fab 2G12, light chain 9606
61 4YGV 2 B, L aDabi-Fab2a light chain 9606
62 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
63 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
64 3EO0 1 A, C GC-1008 Fab Light Chain 10090
65 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
66 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
67 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
68 4JHA 2 L D25 light chain 9606
69 4PTT 1 A Antibody pn132p2C05, light chain 9606
70 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
71 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
72 4DGV 2 L HCV1 Light Chain 9606
73 4NUJ 1 A PGT152 light chain 9606
74 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
75 4NUG 1 L PGT151 light chain 9606
76 3IU4 2 L chP3 Fab light chain 10090
77 3P0Y 3 L Fab DL11 light chain 9606
78 6ANA 3 L LL2 Fab Light Chain 10090
79 5IBU 1 B, L 6652 Light Chain 9606
80 6AOD 1 A FXIa Antibody FAB Light Chain 9606
81 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
82 6ELE 2 B, L fAB light chain 9606
83 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
84 3NAC 1 L Fab15 Mut7 light chain 9606
85 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
86 4YHO 2 L aDabi-Fab3 light chain 9606
87 4DGY 2 L HCV1 Light Chain 9606
88 3MXW 2 L 5E1 light chain 9606
89 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
90 3EO9 1 L Efalizumab Fab fragment, light chain 9606
91 5WUV 1 L light chain 9606
92 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
93 6B0G 1 C 1245 Antibody, Light Chain 9606
94 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
95 6D0X 2 B 1210 Antibody, light chain 9606
96 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
97 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
98 5TL5 1 L M2177 LIGHT CHAIN 10090
99 2FX7 1 L Fab 4E10 Light Chain 9606
100 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
101 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
102 5XKU 2 B HNIgGA6 light chain 9606
103 5I18 1 L FAB LIGHT CHAIN 9606
104 4JN1 2 L anti-dabigatran Fab1, light chain 10090
105 3SOB 1 L antibody light chain 9606
106 6B5M 2 L CIS43 Fab Light chain 9606
107 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
108 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
109 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
110 5DR5 2 L AbD09097 Fab light chain 9606
111 4KQ3 1 L CNTO3186 light chain Fab 9606
112 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
113 4I77 2 L Lebrikizumab light chain Fab 9606
114 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
115 4HJG 1 A Trastuzumab light chain 9606
116 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
117 3FN0 1 L Fab Z13e1 light chain 9606
118 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
119 4YHI 2 B, L aDabi-Fab2a light chain 9606
120 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
121 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
122 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
123 6ELJ 2 B, L fAB light chain 9606
124 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
125 4MAU 1 L C2244 light chain SEE REMARK 999 10090
126 1OP3 1 K, L FAB 2G12, light chain light chain 9606
127 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
128 4LKX 2 B Fab fragment light chain 9606
129 5JW5 2 B, L MEDI8852 Light chain 9606
130 6DCV 1 A, L Light chain of CBTAU27.1 Fab 9606
131 3QWO 1 B, L motavizumab light chain 10090
132 4IOI 1 A Trastuzumab light chain 9606
133 1N7M 1 H Germline Metal Chelatase Catalytic Antibody, chain H 10090
134 5K8A 1 A, E, L, M humanized Fab Lite chain 10090
135 5VAG 2 B Light chain of antibody m826 9606
136 3I9G 2 L Sonepcizumab antibody Fab fragment, light chain Fab Fragment 10090
137 5I16 1 A, L FAB LIGHT CHAIN 9606
138 5F9O 3 L CH235.09 Light chain 9606
139 1UM4 1 L Antibody 21H3 L chain 10090
140 4RBP 1 K, L Fab 2G12 light chain 9606
141 4XVS 2 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 Light chain 9606
142 4FQL 2 L monoclonal antibody CR8033 light chain Fab 9606
143 1NGX 1 A, L Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
144 6DCW 1 L Light chain of CBTAU27.1 Fab 9606
145 5GGQ 1 L nivolumab light chain 9606
146 6B5N 2 L CIS43 Fab Light chain 9606
147 3OAY 1 K, L Fab 2G12, light chain 9606
148 6AND 3 L Pinatuzumab Fab light chain 9606
149 5K9J 2 L 56.a.09 light chain 9606
150 5JRP 1 L marberg virus monoclonal antibody MR78 Fab light chain 9606
151 5TF1 2 L O2-CC Fab Light Chain 9606
152 3TCL 2 B, L CH04 Light Chain Fab 9606
153 4OJF 2 L Humanised 3D6 Fab Light Chain 10090
154 5F7E 2 L Fab light chain 9606
155 1T3F 1 A Huzaf antibody light chain The source is engineered human constant and framework regions with CDRs from mouse 9606
156 5FHA 2 L Antibody 114 Fab light chain 9606
157 5UMN 3 D, F Antibody C05, light chain 9606
158 4X7S 2 L Ig kappa chain C region residues 23-236 9606
159 1UM6 1 L antibody 21h3, L chain 10090
160 4X0K 2 B, L Fab fragment light chain 9606
161 1S3K 1 L HU3S193 Fab fragment, light chain murine complementarity determining regions grafted onto human framework and constant sequences 10090
162 5E8E 1 A IGA FAB LIGHT CHAIN 9606
163 6ELL 2 B, L fAB light chain 9606
164 2HFF 1 A, L CB2 Fab, light chain 9606
165 4M7K 1 L 10H10 light chain SEE REMARK 999 10090
166 1VGE 1 L TR1.9 FAB FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY 9606
167 5GGS 2 B, D light chain 9606
168 5I1L 1 A, L FAB LIGHT CHAIN 9606
169 5GGV 1 L light chain 9606
170 3L5X 1 L H2L6 LIGHT CHAIN 9606
171 5BJZ 3 H, L Synthetic antibody, Fab fragment, Light Chain 9606
172 2NXY 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
173 2R8S 2 L Fab light chain 10090
174 4HKZ 1 A Trastuzumab light chain 9606
175 5CHN 2 B, L Antibody 5M16 Fab Light Chain 9606
176 3SO3 2 B A11 FAB light chain 9606
177 3OAU 2 L Fab 2G12, light chain 9606
178 5WEQ 1 A MR78 mutant light chain 9606
179 4WY7 2 L Fab 4E10Light chain 9606
180 4ZYK 2 B, L AM14 light chain 9606
181 6C9U 2 L Light chain of Fab 1B2 9606
182 5E94 1 A, C Antibody Fab fragment light chain 10090
183 5FB8 1 A Anti-IL-16 antibody 14.1 Fab domain Kappa Chain 10090
184 3U0W 2 L Fab Light Chain, Ig kappa chain C region chimera of Fab Light Chain from mouse, Ig kappa chain C region from human 10090
185 2O5X 1 L chimeric antibody Fab 1E9-DB3 light chain 10090
186 4HIE 1 A Fab 023.102 9606
187 4LEX 1 L FAB HEAVY CHAIN 10090
188 3QEG 2 L Fab fragment of human anti-HIV antibody N12-i2, light chain Fab light chain 9606
189 1CE1 1 L PROTEIN (CAMPATH-1H:LIGHT CHAIN) FAB 9606
190 5ITB 2 L anti-RSV F Fab 14N4 Light chain 9606
191 5Y11 2 B MAb 4-5 light chain 9606
192 2NY2 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
193 4KMT 1 L light chain O12/KAPPA Fab 9606
194 3NZH 1 L 5F6 LIGHT CHAIN 10090
195 1RHH 1 A, C Fab X5, light chain 9606
196 6BLI 2 B, E, H, K CB002.5 Fab Light Chain 9606
197 4JPI 2 B, L Putative VRC01 germline Fab light chain 9606
198 4XTR 3 D, F Antibody Light chain 32630
199 1RZ7 1 L Fab 48d light chain 9606
200 1RZG 2 B, D Fab 412d heavy chain 9606
201 5EA0 2 L Light chain of antibody 7968 Fab fragment 9606
202 3PGF 3 L SAB Light Chain 9606
203 1IQD 1 A HUMAN MONOCLONAL BO2C11 FAB LIGHT CHAIN 9606
204 2NY4 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
205 4YHL 2 L aDabi-Fab2b light chain 9606
206 2NY3 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
207 5I1A 1 A, L CNTO388 LIGHT CHAIN 9606
208 2QQN 3 L Antibody light chain 9606
209 3L5W 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
210 2NY1 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
211 4OGY 3 L, N DX-2930 LIGHT CHAIN 9606
212 4YHM 2 L aDabi-Fab2b light chain 9606
213 1C5B 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
214 3X3F 2 L Light chain of KMTR2 9606
215 2CMR 3 L D5 9606
216 4R4B 1 A, C, E, L FAB 2.2C LIGHT CHAIN 9606
217 5CZX 3 D, L 20358 Fab light chain 9606
218 6BI0 2 L, M Trastuzumab anti-HER2 Fab Light Chain 9606
219 3GRW 2 L Fab light chain 9606
220 6B3K 2 L Light chain of Fab BL3-6 10090
221 6C6Z 3 D, L Antibody CDC2-C2 light chain 9606
222 5I1D 1 A, L FAB LIGHT CHAIN 9606
223 5VKK 2 B, L Epratuzumab Fab Light Chain 10090
224 6AYZ 2 C, D Fab Light Chain 9606
225 3QCU 2 L, M LT3015 antibody Fab fragment, light chain 9606
226 2NXZ 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
227 6CDO 2 B vFP16.02 Fab light chain 10090
228 1UJ3 1 A IgG Fab light chain anti-tissue-factor antibody hATR-5 Fab 9606
229 5DRX 2 B, L CLL240 BCR light chain 9606
230 4HIX 2 L Humanized 3D6 Fab light chain 10090
231 4LKC 1 A Fab fragment of PCSK9 antibody 9606
232 4OM1 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
233 4KZD 2 L BL3-6 Fab antibody, light chain 10090
234 4HCR 2 L, N PF-547659 light chain 9606
235 4CNI 2 B, L OLOKIZUMAB LIGHT CHAIN, FAB PORTION FAB PORTION 9606
236 4HIH 1 A, C Fab 023.102 9606
237 4YHK 2 L aDabi-Fab2a light chain 9606
238 4XH2 2 B, D, F, I, K, L Fab Light Chain 9606
239 5IES 2 L VRC01cHuGL2 Fab light chain 9606
240 4UV7 3 L GC1118A 9606
241 5TKJ 2 B, E, H, K vFP1.01 chimeric mouse antibody light chain 10090
242 3QNX 1 A Fab fragment of IMMUNOGLOBULIN A1 LIGHT CHAIN 9606
243 4OLZ 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
244 3S34 1 L 1121B Fab light chain 10090
245 6AZX 2 B, D 663 antibody, light chain 9606
246 1GAF 1 L CHIMERIC 48G7 FAB BOTH FAB CHAINS ARE DERIVED FROM THE MATURE (HYBRIDOMA LINE) ANTIBODY. THE LIGHT CHAIN CONSISTS OF THE VJ VARIABLE DOMAIN FROM MOUSE AND THE C(KAPPA) CONSTANT REGION FROM HUMAN. THE HEAVY CHAIN CONSISTS OF THE VDJ VARIABLE DOMAIN FROM MOUSE AND THE C(H1) CONSTANT REGION FROM HUMAN VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 9606
247 5E2T 1 L AT8 LIGHT CHAIN 10090
248 6EMJ 2 B, L fAb light chain 9606
249 5W1G 2 L CR1-07 Fab light chain 9606
250 6CNR 1 L Aducanumab light chain 9606
251 2RCS 1 L IMMUNOGLOBULIN 48G7 GERMLINE FAB VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 10090
252 2AJ3 1 A, C, E Fab m18, Light Chain 9606
253 3PNW 1 A, D, G, J, M, P, S, V FAB light chain 32630
254 3QO0 1 A Fab fragment of IMMUNOGLOBULIN G1 LIGHT CHAIN 9606
255 4NRX 3 B, E, L m66 Light Chain 9606
256 3O2D 1 L ibalizumab light chain 10090
257 3HI6 3 L, Y light chain of Fab fragment of AL-57 against alpha L I domain 9606
258 5O14 3 D, L Fab 1A12 Light Chain 9606
259 4ZFG 3 L Fragment antigen binding 5A12 light chain 9606
260 5V7R 1 L CBTAU-7.1 Fab light chain 9606
261 6B5O 2 L CIS43 Fab Light chain 9606
262 1AJ7 1 L IMMUNOGLOBULIN 48G7 FAB (LIGHT CHAIN) VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 10090
263 2R0L 1 L antibody light chain 32630
264 1DN0 1 A, C IGM-KAPPA COLD AGGLUTININ (LIGHT CHAIN) FAB FRAGMENT 9606
265 5BK1 2 D, L Synthetic antibody, Fab fragment, Light Chain 9606
266 3GIZ 1 L Fab fragment of anti-CD20 antibody Ofatumumab, light chain 9606
267 3QNZ 1 A Fab fragment of IMMUNOGLOBULIN G1 LIGHT CHAIN 9606
268 3Q1S 1 L Z13e1 Fab light chain 9606
269 3FO2 1 A, L Catalytic antibody Fab 13G5 kappa light chain chimera FUSION PROTEIN. THE VARIABLE DOMAIN (RESIDUES 1-107) IS FROM A MURINE SOURCE AND THE CONSTANT DOMAIN (RESIDUES 108-214) IS FROM A HUMAN SOURCE 10090
270 5F96 3 L LIGHT CHAIN OF ANTIBODY CH235.12 9606
271 5VR9 2 B, L CH1/Ckappa Fab light chain 9606
272 4OLU 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
273 3KR3 3 L antibody-Fab (light chain) 9606
274 5DK3 1 A, F Light Chain 9606
275 4OLX 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
276 2NY0 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
277 4YHN 2 B, L aDabi-Fab3 light chain 9606
278 5GGU 2 B, L light chain 9606
279 3QO1 1 A Fab fragment of IMMUNOGLOBULIN G1 LIGHT CHAIN 9606
280 4D9Q 2 D, L Anti-Factor D, light chain 9606
281 1A4J 1 A, L IMMUNOGLOBULIN, DIELS ALDER CATALYTIC ANTIBODY (LIGHT CHAIN) FAB 10090
282 5KW9 3 L IgA Light chain 9606
283 3QNY 1 A, C FAB FRAGMENT OF IMMUNOGLOBULIN A1 LIGHT CHAIN 9606
284 1YYM 2 L, Q antibody 17b light chain ANTIGEN-BINDING FRAGMENT, FAB 9606
285 5W2B 2 L Fab Light Chain 9606
286 5DRW 2 B CLL183 BCR antibody light chain 9606
287 1FL5 1 A, L ANTIBODY GERMLINE PRECURSOR TO ANTIBODY 28B4 LIGHT CHAIN (CHAINS L AND A) 10090
288 2O5Z 1 L chimeric antibody Fab 1E9-DB3 light chain 10090
289 4OM0 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
290 5MVZ 2 B, L Fab 4AB007 L-chain 9606
291 3AAZ 2 B, L Humanized recombinant Fab fragment of a murine; antibody 9606
292 4QXG 2 L Fab, light chain, IgG1 Fab, light chain 9606
293 3O2V 1 L Chimeric antibody Fab 1E9, light chain 10090
294 2I5Y 2 L, Q Antibody 17B Light chain ANTIGEN-BINDING FRAGMENT, FAB 9606
295 2FX9 1 L, M Fab 4E10 Light Chain 9606
296 3C08 1 L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090
297 6AXL 1 B, C Fab317 light chains 9606
298 1BZ7 1 A PROTEIN (ANTIBODY R24 (LIGHT CHAIN)) FAB 10090
299 1TZG 1 L, M Fab 4E10 light chain 9606
300 3W9D 2 B, D Antibody Fab light chain 9606
301 6CO3 1 L Fab light chain 9606
302 4NRZ 2 B, L M66.6 LIGHT CHAIN Fab Light Chain 9606
303 3BN9 2 C, E E2 Fab Light Chain 9606
304 4HWE 2 L Fab light chain light chain 9606
305 5TZ2 2 L C47B222 Fab Light Chain 9606
306 6CDM 2 B, E vFP7.04 light chain 10090
307 3L95 1 A, L anti-NRR1 fab fragment light chain 9606
308 4OGX 3 L DX-2930 LIGHT CHAIN 9606
309 3W9E 3 B Antibody Fab light chain 9606
310 5TFS 2 L 02-K Fab Light chain 9606
311 3UTZ 1 A, D, E Metalloproteinase, light chain 10090
312 5E2U 1 L AT8 LIGHT CHAIN 10090
313 1OM3 1 L, M FAB 2G12, light chain light chain 9606
314 4KZE 2 L BL3-6 Fab antibody, light chain 10090
315 5WT9 2 L Light Chain of Nivolumab 9606
316 4HIJ 1 A, C Fab 023.102 light chain 9606
317 3FO1 1 A, L Catalytic antibody Fab 13G5 kappa light chain chimera FUSION PROTEIN. THE VARIABLE DOMAIN (RESIDUES 1-107) IS FROM A MURINE SOURCE AND THE CONSTANT DOMAIN (RESIDUES 108-214) IS FROM A HUMAN SOURCE 10090
318 4XVU 3 D, F, J, L Antibody light chain 32630
319 5B71 1 A, C SKY59 Fab light chain 9606
320 6BF4 3 C, L VRC-PG05 Fab light chain 9606
321 3QCT 2 L LT3015 antibody Fab fragment, light chain 9606
322 3EYF 1 A, C 8f9 Fab 9606
323 3NAB 1 L Fab15 Mut6 light chain 9606
324 4Q9Q 2 L Fab BL3-6, LIGHT CHAIN 10090
325 5I1C 1 L FAB LIGHT CHAIN 9606
326 5VZY 2 L Crenezumab Fab light chain,Immunoblobulin light chain 9606
327 5WNA 2 D, L mAb 3D3 Fab light chain 9606
328 1RZ8 1 A, C Fab 17b light chain 9606
329 4WV1 3 A, D Fab light chain 9606
330 6ANP 1 A, L CAT192 Fab Light chain 9606
331 5EII 2 B, L Fab Light Chain 9606
332 5KZP 2 I, J, K, L HCV1-C1 Antibody Fab Light Chain 9606
333 4OLY 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
334 4FNL 2 L, M Antibody C05, Light Chain 9606
335 4UB0 2 L IgG1, light chain 9606
336 1FVD 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606
337 1BJ1 1 J, L FAB FRAGMENT HUMANIZED VERSION OF A MONOCLONAL MURINE ANTI-VEGF ANTIBODY 10090
338 5I1H 1 L FAB LIGHT CHAIN 9606
339 2FX8 1 L, M, N, O Fab 4E10 Light Chain 9606
340 1NGY 1 A Mature Metal Chelatase Catalytic Antibody, Light chain Fab fragment 10090
341 5I1J 1 L FAB LIGHT CHAIN 9606
342 3IDX 3 L Fab b13 light chain 9606
343 5CIP 2 B, L FAB 4E10 LIGHT CHAIN 9606
344 6AO0 1 L CAT192 Fab Light chain 9606
345 1ZLV 1 K, L FAB 2G12, light chain FAB, Light Chain 9606
346 5IF0 2 B, L VRC01c-HuGL2 Fab light chain 9606
347 4K94 1 L Fab19 heavy chain 9606
348 1ZLS 1 L FAB 2G12, light chain FAB, Light Chain 9606
349 5K9Q 4 I, K, L, T, V, Y 16.a.26 Light chain 9606
350 6B5L 2 L CIS43 Fab Light Chain 9606
351 1I7Z 1 A, C CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION THE CHIMERA CONSISTS OF RESIDUES 1-108 OF MOUSE PORTION AND 109-214 OF HUMAN PORTION OF IG KAPPA CHAIN. 10090
352 4JPK 2 L Putative VRC01 germline precursor Fab light chain 9606
353 5XAJ 2 B, L FabHM14c10 light chain 9606
354 4ZD3 2 L 679-14-14E06 Fab fragment light chain 9606
355 5VEB 2 B, L anti-CDH6 Fab light chain 9606
356 5VZX 2 I, L Crenezumab Fab light chain 9606
357 3FCT 1 A, C PROTEIN (METAL CHELATASE CATALYTIC ANTIBODY) CHIMERIC FAB FRAGMENT FAB FRAGMENT 9606
358 3X3G 2 L Light chain of KMTR2 9606
359 5WAW 1 L fAb Light Chain 9606
360 5E08 2 L Fab Light Chain 9606
361 6AZ2 3 E, F Fab Light Chain 9606
362 1CZ8 2 L, X LIGHT CHAIN OF NEUTRALIZING ANTIBODY MUTATED FORM OF A HUMANIZED MURINE ANTIBODY LIGHT CHAIN 10090
363 5IBT 2 L UCA Light Chain 9606
364 4XAK 3 E, L Light chain of neutralizing antibody m336 9606
365 5JQ6 3 L Tefibazumab FAB FRAGMENT LIGHT CHAIN 10090
366 1A4K 1 A, L ANTIBODY FAB FAB 10090
367 5MO9 2 L AB20 Fab light chain 10090
368 3HR5 1 A, L, P, Q Fab h47H4 light chain 10090
369 6AL4 1 A, C, E B43 LIGHT CHAIN 9606
370 2I60 2 L, Q ANTIBODY 17B LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
371 4NGH 1 L FAB LIGHT CHAIN 9606
372 5WB9 3 L N60P23 Fab light chain 9606
373 4EDW 2 L tanezumab Fab light chain 9606
374 1UCB 1 L CHIMERIC HUMAN/MOUSE IGG FAB FRAGMENT BR96 MOUSE VH AND VL DOMAINS, HUMAN CL KAPPA AND CH1 IGG1 DOMAINS 9606
375 1FVE 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606
376 2NY5 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
377 4NM4 1 L, M Antibody CR8043, Light Chain 9606
378 4LST 3 L LIGHT CHAIN OF ANTIBODY VRC01 9606
379 3U7Y 3 L NIH45-46 light chain, Ig kappa chain C region 9606
380 4D9R 2 D, L Fab light chain 9606
381 3U7W 2 L Light chain, Ig kappa chain C region 9606
382 2H9G 1 A, L Fab BdF1, light chain Fab fragment 9606
383 4G7V 2 L fragment antibody light chain 9606
384 5W06 2 L M1587 FAB LIGHT CHAIN 10090
385 4HFW 1 A, L 6-26 Fab Light chain 9606
386 3L7E 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
387 2XRA 3 L HK20, HUMAN MONOCLONAL ANTIBODY LIGHT CHAIN 9606
388 4LIQ 3 L Fab fragment RG7155 light chain Humanized Version of a monoclonal murine. 10090
389 4S1Q 3 L Fab of VRC01 light chain Fab of VRC01 light chain 9606
390 5JO4 2 B D80 Fab Light Chain 9606
391 5JO4 4 D G6 Fab Light Chain 9606
392 4KQ4 1 L CNTO7357 light chain Fab (mouse variable domain, human constant domain) 10090
393 3INU 2 L, N KZ52 antibody fragment light chain 9606
394 5EU7 3 C, D FAB light chain 9606
395 4OLV 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
396 1DFB 1 L IGG1-KAPPA 3D6 FAB (LIGHT CHAIN) 9606
397 2EH7 1 L HUMANIZED KR127 FAB, LIGHT CHAIN 10090
398 6CDP 2 B vFP20.01 Fab light chain 10090
399 5X8M 3 C durvalumab light chain 9606
400 6AMJ 1 A, L CAT192 Fab light chain 9606
401 1RZJ 3 L ANTIBODY 17B, LIGHT CHAIN FAB 9606
402 4HII 1 A, C Fab 023.102 light chain 9606
403 2EH8 1 L HUMANIZED KR127 FAB, LIGHT CHAIN 10090
404 1AD0 1 A, C ANTIBODY A5B7 (LIGHT CHAIN) FAB FRAGMENT 9606
405 4DN3 1 L CNTO888 LIGHT CHAIN 9606
406 4U6V 2 L, M Fab, antigen binding fragment, light chain 9606
407 4LSS 3 L LIGHT CHAIN OF ANTIBODY VRC01 with N72T mutation 9606
408 5WNB 2 L, M mAb 3D3 Fab light chain 9606
409 2XA8 2 L OMALIZUMAB LIGHT CHAIN 9606
410 3EYV 1 A, L hu3S193 Fab, light chain 10090
411 1GC1 3 L ANTIBODY 17B MONOCLONAL ANTIBODY 17B BINDS TO A CD4-INDUCED SITE ON GP120 ANTIGEN-BINDING FRAGMENT, FAB 9606
412 1HKL 1 L 48G7 FAB VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 9606
413 3PP3 2 K, L GA101 Fab light chain 10090
414 5IJK 3 C, D 1E03 Fab fragment light chain 9606
415 3BDY 2 L Fab Fragment -Light Chain 9606
416 5I8E 2 B, D VRC34.01 Fab light chain 9606
417 3FZU 1 D, L immunoglobulin IgG1 Fab, light chain 9606
418 1G9M 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
419 5UIX 2 L DH576 Fab light chain 9606
420 3K2U 4 L Antibody, Fab fragment, Light Chain 9606
421 4HWB 3 L Fab light chain 9606
422 5VSH 2 B, D, F, L CH1/Clambda Fab light chain 9606
423 3O2W 1 L Chimeric antibody Fab 1E9, light chain 10090
424 1PG7 2 L, M humanized antibody D3H44 antigen-binding fragment 10090
425 2HFG 1 L CB3s Fab light chain (kappa) 9606
426 3GKW 2 L Light chain of the antibody Nimotuzumab 9606
427 3JWD 3 L, O FAB 48D LIGHT CHAIN 9606
428 4JQI 3 L Fab30 light chain 10090
429 6B0H 3 A, C 1262 antibody, light chain 9606
430 3SKJ 1 L, M Antibody, light chain 9606
431 3U30 2 B, E Light chain Fab 9606
432 6B0A 2 L 1269 antibody, light chain 9606
433 3QCV 2 L, M LT3015 antibody Fab fragment, light chain 9606
434 3U0T 1 A, C ponezumab LC Fab 9606
435 5HYS 2 B, D, F, L Uncharacterized protein 9606
436 3FO0 1 L Catalytic antibody Fab 13G5 kappa light chain chimera FUSION PROTEIN. THE VARIABLE DOMAIN (RESIDUES 1-107) IS FROM A MURINE SOURCE AND THE CONSTANT DOMAIN (RESIDUES 108-214) IS FROM A HUMAN SOURCE 10090
437 3L7F 1 A, D, L H2L6 LIGHT CHAIN 9606
438 5I15 1 L FAB LIGHT CHAIN 9606
439 2FJF 1 A, C, E, G, J, L, M, O, Q, S, U, W Light Chain of a VEGF binding Antibody 9606
440 5I1E 1 L FAB LIGHT CHAIN 9606
441 2NYY 2 C CR1 monoclonal antibody light chain 9606
442 2GCY 1 A huC25 fab fragment light chain 10090
443 4JLR 2 B, L Motavizumab Fab light chain 9606
444 2QQK 3 L Antibody Light Chain 9606
445 4J1U 1 A, C, E antibody 93F3 Light chain 10090
446 5N4G 2 L LIGHT CHAIN 9606
447 3NGB 3 C, F, K, L Antigen binding fragment of light chain: Antibody VRC01 9606
448 4RRP 1 A, B, C, D, E, F Fab antibody, light chain 9606
449 5SX5 1 K, L Panitumumab Fab Light Chain 9606
450 5JQD 1 A, B D80 Fab Fragment Light Chain 9606
451 4XGZ 2 B, D, F, I, K, L, N, P, R, T, V, X FAB LIGHT CHAIN 9606
452 1N8Z 1 A Herceptin Fab (antibody) - light chain 10090
453 4OAW 1 A, C Light chain of Fab fragment of anti-HIV1 gp120 V2 mAb 2158 9606
454 4KXZ 3 I, L, M, P GC1008 Light Chain 9606
455 5BK2 3 D, L sAB Light Chain 9606
456 1TZH 2 A, L Fab YADS1 Light Chain 10090
457 5O1R 3 L, M Uncharacterized protein 9606
458 6CMI 2 C m102.3 light chain 9606
459 4XML 1 L Light chain of HIV-1 gp120 V3-specific human monoclonal antibody 2424 9606
460 4JZJ 3 B, L Fab Light Chain 10090
461 5BMF 2 L Fab fragment light chain 9606
462 5BO1 3 L, M Fab light chain 9606
463 6FOE 2 B, L Fab BaxB01 light chain engineered Fab light chain binds oxidized macrophage migration inhibitory factor (MIF) 9606
464 4M6O 1 L CNTO7309 light chain 9606
465 3QEH 2 B, D, F, H Fab fragment of human anti-HIV-1 Env antibody N12-i15,light chain Fab light chain 9606
466 4OLW 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
467 5LSP 3 L, T 107_A07 Fab light chain 9606
468 4DVR 2 L Fab 48d Light chain 9606
469 3EYQ 1 C M2J5 Fab 9606
470 5BK3 1 B, D, F, L 580 Antibody, light chain 9606
471 4XWO 3 D, F, J, L, P, R, V, X Antibody light chain 32630
472 2O5Y 1 L chimeric antibody Fab 1E9-DB3 light chain 10090
473 4ZFF 2 B, L Fragment antigen binding (Fab) 5A12 Light chain 9606
474 3HI5 2 L light chain of Fab fragment of AL-57 against alpha L I domain 9606
475 4XXD 1 A, D Fab Light Chain 9606
476 5F9W 3 C, L Light chain of CH235-lineage antibody CH235 9606
477 1CLY 1 L IGG FAB (HUMAN IGG1, KAPPA) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER CHIMERIC FRAGMENT (BR96) 9606
478 4XBG 1 B, D, F, I, K, L 4E10 Fab light chain 9606
479 1YYL 2 L, Q antibody 17b light chain ANTIGEN-BINDING FRAGMENT, FAB 9606
480 2NY6 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
481 5FUZ 2 L 645 FAB, LIGHT CHAIN 9606
482 3DVG 1 A Human IgG1 fab fragment light chain 9606
483 4HS8 3 L antibody hu5B3.v2 Fab light chain 9606
484 2AGJ 1 L Yvo Fab, Light Chain 9606
485 4JKP 3 L Light chain of antibody 45-46M2 9606
486 3EYO 1 A, C 8f9 Fab 9606
487 1B6D 1 A, B IMMUNOGLOBULIN IMMUNOGLOBULIN LIGHT-CHAIN DIMER 9606
488 5BZD 1 A, C 5G8 HIV Antibody light chain 9606
489 3NFS 1 L Heavy chain of Fab fragment of daclizumab 9606
490 3B2U 1 D, G, K, L, O, R, U, X IMC-11F8 Fab Light chain 9606
491 4DN4 1 L CNTO888 LIGHT CHAIN 9606
492 5TRP 2 L DH272 Fab light chain 9606
493 2FGW 1 L H52 FAB (LIGHT CHAIN) 9606
494 1B2W 1 L PROTEIN (ANTIBODY (LIGHT CHAIN)) V DOMAIN AND C DOMAIN 10090
495 2FJG 2 A, L Fab light chain 9606
496 4DKF 3 L, M FAb2 Light Chain 9606
497 5TLK 1 A, E M2177 LIGHT CHAIN 10090
498 5TLK 3 C, G H2191 LIGHT CHAIN 10090
499 1UWE 2 L, U, X ANTIBODY 14D9 FAB LIGHT CHAIN, RESIDUES 1-212 10090
500 1HEZ 1 A, C KAPPA LIGHT CHAIN OF IG 1-214 9606
501 1IT9 1 L HUMANIZED ANTIBODY HFE7A, LIGHT CHAIN FAB FRAGMENT 10090
502 3EFD 1 L FabL 10090
503 4LF3 1 A, D Fab heavy chain 10090
504 5K59 4 F, L Fab light chain 9606
505 1UWG 2 L, X ANTIBODY 14D9 CATALYTIC ANTIBODY 19C9 FAB LIGHT CHAIN, RESIDUES 1-213 10090
506 5KN5 2 B, E Epiregulin Antibody LY3016859 Fab Light Chain 9606
507 4XCN 1 B, D, F, I, K, L 4E10 Fab light chain 9606
508 5F3H 2 B, D, F, H humanized RK35 antibody light chain 10090
509 4LEO 2 B RG7116 Fab light chain 10090
510 4G7Y 2 L Fragment antibody light chain 9606
511 6B3S 3 D, G, K, L Necitumumab Fab Light chain 9606
512 4PY8 4 J antibody 3.1 light chain Fab 9606
513 3SDY 4 L Antibody CR8020, Light Chain 9606
514 3DVN 1 A, L Human IgG1 fab fragment light chain 9606
515 3IXT 1 B, L Motavizumab Fab light chain 10090
516 6FAX 1 L Lob 7.4 light chain 9606
517 4NP4 3 L, M bezlotoxumab light chain 9606
518 3UC0 3 L, M Light chain, monoclonal antibody 5H2 Fab 9598
519 4XCE 1 B, D, L 4E10 Fab light chain 9606
520 5I1I 1 L FAB LIGHT CHAIN 9606
521 4NNP 3 L, Y Light chain of antagonistic fab fragment 9606
522 4ERS 1 L Fab light chain 9606
523 1DEE 1 A, C, E IGM RF 2A2 FAB LIGHT CHAIN 9606
524 4MWF 2 B, L Fab AR3C light chain 9606
525 2WUC 5 L FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606
526 3SQO 3 L J16 Light chain 9606
527 4K3J 4 L Onartuzumab Fab light chain 10090
528 4PS4 1 L M1295 LIGHT CHAIN 9606
529 5GGT 3 L IGK@ protein 9606
530 3HI1 2 A, L F105 Light Chain 9606
531 4PY7 2 B, J antibody 3.1 light chain Fab 9606
532 6AL5 2 L B43 LIGHT CHAIN 9606
533 4K8R 3 C Fab1, light chain 9606
534 1RZK 3 L ANTIBODY 17B, LIGHT CHAIN FAB 9606
535 5VOB 7 L Fab 8I21 light chain 9606
536 6CMG 2 B m102.3 light chain 9606
537 1ZLU 1 K, L FAB 2G12, light chain FAB, Light Chain 9606
538 1G9N 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
539 1TZI 1 A Fab YADS2 Light Chain 10090
540 1QLR 1 A, C IGM KAPPA CHAIN V-III (KAU COLD AGGLUTININ) FAB FRAGMENT 9606
541 4KUZ 1 L antibody 4A5 light chain Fab (mouse variable domain, human constant domain) 10090
542 4X7T 2 B, L Omalizumab-Fab Light chain 9606
543 4YK4 1 B, Y 641 I-9 VLCL antibody 9606
544 2QSC 1 L Fab F425-B4e8, Light chain Light chain 9606
545 1MHP 3 L, Y FAB FRAGMENT, light chain 10090
546 4N9G 2 B, F, L, N Antibody 17HD9, Light Chain 9544
547 5XMH 2 C, L YES8c light chain 9606
548 1FL6 1 A, L ANTIBODY GERMLINE PRECURSOR TO 28B4 LIGHT CHAIN (CHAINS L AND A) 10090
549 5U3J 2 L DH511.1 Light Chain Fragment of antigen binding 9606
550 3R1G 3 L FAB of YW412.8.31 antibody light chain 9606
551 5I1G 1 L FAB LIGHT CHAIN 9606
552 2QQL 3 L Antibody Light Chain 9606
553 4XCC 1 L 4E10 Fab light chain 9606
554 4MXV 2 E, L, X anti-Lymphotoxin alpha antibody light chain Fab 9606
555 5SX4 1 I, L Panitumumab Fab Light Chain 9606
556 3WD5 2 L Adalimumab Light Chain 9606
557 4NHC 1 L FAB LIGHT CHAIN 9606
558 3EOA 1 A, L Efalizumab Fab fragment, light chain 9606
559 5GZO 3 D, L Antibody light chain 9606
560 2HH0 1 L Light Chain, P-Clone Fab, Chimera 2-109 (mouse), 110-271 (human) 10090
561 2WUB 4 L, Q FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606
562 5GMQ 3 C MCA1 light chain 9606
563 4KY1 1 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN muHP1/2 CDRs + human kappa B3 germline VL framework 9606
564 1ZLW 1 K, L FAB 2G12, light chain FAB, Light Chain 9606
565 4HFU 4 L Fab 8M2 light chain 9606
566 5TRU 1 L, l Ipilimumab Fab light chain 9606
567 4FP8 3 L, M, N, O Antibody C05, light chain 9606
568 4YPG 1 A, L Sifalimumab light chain 9606
569 3BE1 3 L Fab Fragment-Light Chain 9606
570 2FJH 2 A, L Fab fragment light chain 9606
571 5XEZ 3 D, L Antibody, mAb1, light chain 9606
572 4K9E 1 L light chain 10090
573 3P0V 1 L, M Fab DL11 light chain 9606
574 2OQJ 1 A, D, G, J Fab 2G12 light chain 9606
575 4FZ8 2 L FAB light chain of human ANTI-HIV-1 ENV ANTIBODY C11 9606
576 5VIG 2 B, L Fab light chain 9606
577 4UTA 3 L, M BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8 LIGHT CHAIN FAB FRAGMENT 9606
578 3HMX 3 L USTEKINUMAB FAB LIGHT CHAIN 9606
579 4KVN 3 L Human IgG Light Chain 9606
580 4KUC 2 D, E mAb6c2 fab-Heavy chain 10090
581 5VYF 1 A, L Antibody light chain 10090
582 4K7P 1 X antibody rhumAb6 Fab fragment light chain Fab rhumAb6 9606
583 5WUX 2 B, D, L light 9606
584 3OB0 1 K, L Fab 2G12, light chain Fab 9606
585 1T04 1 A, C Huzaf Antibody Light Chain The source is engineered human constant and framework regions with CDRs from mouse. 9606
586 5VQM 2 C, L PA41 FAB LIGHT CHAIN 9606
587 6GK7 1 L HUMAN FAB ANTIBODY FRAGMENT OF CBTAU-27.1(S31Y,T100I) FAB ANTIBODY FRAGMENT 9606
588 3ZTN 4 L FI6V3 ANTIBODY LIGHT CHAIN 9606
589 5DUM 2 L 65C6 Light Chain 9606
590 4I18 1 B, L antibody light chain Fab 10090
591 4Q9R 2 L Fab BL3-6, LIGHT CHAIN 10090
592 3KYM 1 A, C, E, G, I, K, M, O Light Chain Li33 IgG2 9606
593 3IDY 3 C, L Fab b13 light chain 9606
594 4OQT 2 L Light Chain of Li81 Fab, kappa 3 9606
595 3IVK 1 B, L Fab light chain man 10090
596 3KYK 2 L Light Chain Li33 IgG1 9606
597 5TGB 2 B, L 02-CB Fab Light Chain 9606
598 5I19 1 L FAB LIGHT CHAIN 9606
599 5TH9 1 L, M, N GS-5745 Fab light chain 9986
600 5JOF 2 B, D, F, L VRC03 gLV light chain 9606
601 4IRZ 2 L Fab Natalizumab light chain 9606
602 5X8L 2 K, L, M, N, O atezolizumab light chain 9606
603 5UDC 2 C, G, L MEDI8897 Fab Light Chain 9606
604 6GK8 2 L HUMAN FAB ANTIBODY FRAGMENT OF CBTAU-28.1(S32R;E35K) FAB ANTIBODY FRAGMENT 9606
605 5FEC 2 B, L germline 3BNC60 light chain 9606
606 1RZI 1 A, C, E, G, I, K, M, O Fab 47e light chain 9606
607 2R56 2 L, M IgE Fab Fragment, light chain 9606
608 1ZA6 1 A, C, E, G IGG Light chain 9606
609 4YWG 1 L, M Light chain of anti-HIV-1 gp120 V1V2 antibody 830A 9606
610 4ZS6 1 D, L fab Light Chain 9606
611 4Z5R 2 A, J, L, P, R, T, V, Y anti-IFN-a antibody rontalizumab light chain 9606
612 6APB 3 L ADI-14359 Fab Light Chain 9606
613 1U6A 1 L F105 LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
614 4XBP 1 B, D, F, L 4E10 FAB LIGHT CHAIN 9606
615 5K9K 2 B, L 56.a.09 Light chain 9606
616 1NGW 1 A, L Mature Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
617 5BZW 1 A 2B3 HIV Antibody light chain EIVLTQSPGTLSLSPGERATLSCRASQSVSAKNLAWYQQKPGQTPRLLMYGVSLRNTGVP DRFSGSGSGTDFTLTISRLEPEDSAVYFCQQYGTSPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC 9606
618 5W4L 6 C, E Antibody N12-i3 light chain 9606
619 5CD3 2 B, D, F, H DRVIA7 Light Chain 9606
620 6D01 2 B, D, F, H 1210 Antibody, Light chain 9606
621 5CZV 3 L Fab 20350 light chain 9606
622 5XF1 3 D, L Antibody mAb1 Light chain 9606
623 4P59 3 L MOR09825 Fab fragment light chain 9606
624 5XXY 2 L light chain of atezolizumab fab 9606
625 5CJO 3 L FAB light chain 10090
626 4LMQ 3 I, L Stromal cell-derived factor 1 9606
627 3N85 2 L Fab37 Light Chain 9606
628 6AMM 1 L CAT192 Fab Light chain 9606
629 3G6J 3 E, G Fab light chain 9606
630 5GJT 3 L light chain of human neutralizing antibody 3E1 light chain of neutralizing antibody 3E1 9606
631 3HMW 1 L USTEKINUMAB FAB LIGHT CHAIN 9606
632 6B9J 3 B, L Fab vv138 Light chain 9606
633 5O4G 2 A MF3958 FAB light chain 9606
634 2QAD 3 C, G anti-HIV-1 antibody 412d light chain FAB, ANTIGEN-BINDING FRAGMENT 9606
635 4DKE 3 L, M FAb1.1 Light Chain 9606
636 5A3I 4 D, H ANTI-HAEMAGGLUTININ HA1 FAB LIGHT CHAIN 9606
637 5I17 1 A, L FAB LIGHT CHAIN 9606
638 5VIC 2 L Fab light chain 9606
639 3NFP 2 B, L Light chain of Fab fragment of daclizumab 9606
640 1BEY 1 L CAMPATH-1H ANTIBODY FAB FRAGMENT 9606
641 4R8W 4 L Light chain of neutralizing antibody CT149 9606
642 5TPN 3 L hRSV0 light chain 9606
643 5GJS 3 L light chain of human neutralizing antibody 3E1 9606
644 1I9R 3 L, M, Y IMMUNOGLOBULIN L 9606
645 4NRY 1 B, L m66 Heavy Chain 9606
646 4XMK 1 L, M, N Light chain of HIV-1 gp120 V3-specific human monoclonal antibody 2424 9606
647 3S37 1 L 1121B Fab light chain 10090
648 5TZT 1 B, L Light Chain of Fab C47B161 9606
649 5XHF 1 A, C polypeptide (L chain) 10090
650 5VL7 4 L Fab33 light chain 9606
651 1PKQ 1 A, F (8-18C5) chimeric Fab, light chain 10090
652 5JXE 2 C, F Pembrolizumab Fab light chain 9606
653 5KZC 3 D, G, L VRC01 Fab light chain 9606
654 4JM2 3 C 17b Light chain Fab 9606
655 1S78 2 C, E Pertuzumab Fab light chain 10090
656 1OP5 1 K, L FAB 2G12, light chain light chain 9606
657 5BK0 1 A, C 663 Antibody, light chain 9606
658 4UV4 2 L FPRO0165 FAB LIGHT CHAIN 9606
659 4NYL 1 B, D, F, L Adalimumab Light Chain 9606
660 5D1Z 1 A, H Y10 Light Chain 9606
661 5D1Z 3 C, E D4-10 Light Chain 9606
662 5GGR 2 B, L light chain 9606
663 5IBL 4 D, L 6639 Light Chain 9606
664 4XHJ 3 C, G Fab-RC light chain 9606
665 4JDT 3 L Fab light chain NIH45-46 LIGHT CHAIN 9606
666 5O4O 1 A MF3178 FAB light chain 9606
667 5HJ3 4 B, F, J, N KZ52 Antibody Fragment 9606
668 4N90 3 E, G, I Fab light chain 9606
669 5BK5 2 A, C, E, G 663 germline antibody, light chain 9606
670 5VGJ 3 L VRC38.01 Fab Light Chain 9606
671 4UBD 4 D, H, L, P, T, X monoclonal antibody L chain 9606
672 6B0E 1 A 1260 antibody, light chain 9606
673 5D1Q 1 A D2-06 Light Chain 9606
674 5D1Q 4 D P5 Light Chain 9606
675 1ZA3 1 A, L Fab-YSd1 light chain Fab light chain 9606
676 3UAJ 3 D, L Light chain, monoclonal antibody 5H2 Fab 9598
677 3EO1 1 A, D, G, J GC-1008 Fab Light Chain 10090
678 3C09 1 B, L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090
679 5XHV 3 L, Q S40 light chain 9606
680 4IOF 3 D, F Fab-bound IDE, light chain 10090
681 5FUO 3 L FAB LIGHT CHAIN 9606
682 4JHW 2 L D25 light chain 9606
683 4HG4 4 K, M, O, Q, S, U, W, Y, z Fab 2G1 light chain 9606
684 3ZTJ 4 H, J, L FI6V3 ANTIBODY LIGHT CHAIN 9606
685 4M1C 3 D, F Fab-bound IDE, light chain 9606
686 5UQY 3 C, G, K, O MR78 Fab light chain 9606
687 2JIX 1 A, G, L ABT-007 FAB FRAGMENT 9606
688 3ULV 2 L Fab15 light chain 9606
689 5UG0 3 C 2897 light chain 9606
690 4M7L 2 L 10H10 light chain SEE REMARK 999 10090
691 4S1R 3 L Fab of VRC01 light chain Fab of VRC01 light chain 9606
692 4MXW 5 L, V anti-Lymphotoxin alpha antibody light chain Fab 9606
693 5UOE 3 L, N, Q, T, W FAB light chain 9606
694 5VL3 3 B, D, F, L Epratuzumab Fab Light Chain 10090
695 5D1X 1 A D4-30 Light Chain 9606
696 5D1X 4 D P5 Light Chain 9606
697 5JW3 4 L MEDI8852 light chain 9606
698 5WKO 2 B, D, F, H, J, L Antibody 27F3 light chain 9606
699 5UMI 2 B, L PA50 Fab Light chain 9606
700 6D11 2 B, D 1450 Antibody, Light chain 9606
701 6APD 3 E, G, I AM22 Fab Light Chain,Uncharacterized protein 9606
702 2NZ9 2 C, E AR2 monoclonal antibody light chain 9606
703 3S36 1 L 1121B light chain 10090
704 5CWS 1 A, G sAB-158 Fab Light Chain 9606
705 5I5K 3 L, Y Eculizumab light chain (variable domain) 9606
706 4S1S 3 L Fab of VRC01 light chain Fab of VRC01 light chain 9606
707 2R0K 2 L antibody light chain of Fab58 9606
708 3CSY 2 B, D, F, H Fab KZ52 light chain light chain 9606
709 5C8J 2 B, D, F, H Antibody fragment, light chain OBTAINED BY PHAGE DISPLAY FROM A LIBRARY OF HUMAN IGG. ANTIBODY FRAGMENT; THE CDRS ARE COMPLETELY SYNTHETIC 9606
710 4R4F 2 L Antibody 2.2c LIGHT CHAIN 9606
711 4G80 3 B, D, F, H fragment antibody light chain 9606
712 3JWO 3 L FAB 48D LIGHT CHAIN 9606
713 5CD5 3 D DRVIA7 Fab Light Chain 9606
714 3P11 2 L Fab DL11 light chain 9606
715 3F12 1 A, C M2J1 Fab 9606
716 3B2V 1 L IMC-11F8 FAB Light chain 9606
717 5IGX 3 L germline NIH45-46 light chain 9606
718 3ULU 2 L Fab15 light chain 9606
719 5KAQ 3 G, L, R ANTIBODY 31.A.83 FAB LIGHT CHAIN 9606
720 6ATT 3 L Antibody 39S Fab light chain Antibody, light chain 9606
721 5W1K 1 A, F, K, S CR1-28 Fab light chain 9606
722 5W1K 3 C, H, M, N CR1-10 Fab light chain 9606
723 4XI5 3 C Fab-94 light chain 9606
724 5WOB 4 J, L, N, P, R, T, V, X IDE-bound Fab light chain 60742
725 3EOB 1 A, L Efalizumab Fab fragment, light chain 9606
726 5G64 3 L, M FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-218 9606
727 4NM8 3 L, M, N Antibody CR8043, Light Chain 9606
728 5W1M 1 A, C, E, G CR1-07 Fab light chain 9606
729 4XCY 1 B, D, F, I, K, L 4E10 Fab light chain 9606
730 5K9O 2 B, L 31.b.09 Light Fv 9606
731 5TLJ 1 A, E M2177 LIGHT CHAIN 10090
732 5TLJ 3 C, G M2191 LIGHT CHAIN 10090
733 5JW4 4 N, P, T, V, X MEDI8852 light chain 9606
734 5JW4 6 R MEDI8852 light chain 9606
735 2QR0 1 A, E, G, K, M, Q, S, W Fab-Fragment Light Chain 9606
736 5UDD 3 P, Q, R, S, T, U MEDI8897 Fab Light Chain 9606
737 5VOC 7 L Fab 8I21 light chain 9606
738 5J3D 2 B, D, L 14N4 light chain 9606
739 2B4C 3 L anti-HIV-1 gp120 immunoglobulin X5 light chain 9606
740 5ESZ 2 B, L CH04 Light Chain 9606
741 4R4N 3 D, G, K, L, O, R, U, X Antibody 2.2c LIGHT CHAIN 9606
742 3EFF 1 A, C FAB 10090
743 3PJS 1 A, C FAB light chain 10090
744 5O7P 2 A MF3178 FAB light chain 9606
745 4ZYP 3 L, M, O Motavizumab antibody light chain 10090
746 4ZYP 5 E, G, I AM14 antibody light chain 9606
747 6B3M 4 D, J, N, P, U, W 70-1F02 Fab Light Chain 9606
748 5DWU 4 L Fab - Light Chain 9606
749 5V2A 3 L Light chain (kappa) of H7.167 antibody Fab 9606
750 5I8H 5 F, H VRC34.01 Fab light chain 9606
751 4RQS 2 C 17b Fab Light Chain 9606
752 4FQR 4 b, d, f, h, j, l, n, p, r, t, v, x Broadly neutralizing antibody C05, light chain 9606
753 4R4H 3 L Antibody 2.2c, Light chain 9606
754 5VOD 7 L Fab 9I6 light chain 9606
755 5FHC 5 L Antibody 114 Fab light chain 9606
756 4XMN 6 L Antibody 87 light chain 32630
757 4XMM 8 L Antibody 57 light chain 9606
758 4NHH 1 F, G, K, L, P, Q 2G12 IgG dimer light chain 9606
759 4NHG 2 B, C, F, G, K, L 2G12 IgG dimer light chain 9606
760 6CDE 2 4, L, l vFP20.01 Light chain 9606
761 6CDI 8 4, L, l vFP16.02 Light Chain 9606
762 6BF7 3 D, F Fab H11-E light chain 10090
763 6BF9 3 D, F Fab H11-E light chain 10090
764 6B7Z 3 D, F FAB H11 light chain 10090
765 6B70 3 D, F FAB H11-E light chain 10090
766 5VN3 1 L, N, O 17b Fab light chain 9606
767 5GZR 4 L, N Z23 Fab light chain 9606
768 5THR 4 J, K, L 17b Fab VL domain 9606
769 5FUU 4 L, N IMMUNOGLOBULIN G PGT151 PGT151 CLEAVED INTO FAB FAB LIGHT CHAIN VARIABLE REGION, RESIDUES 1-214 9606
770 5A8H 3 C, I, O FAB OF BROADLY NEUTRALIZING ANTIBODY 17B 9606
771 5A7X 3 C, G, K FAB OF BROADLY NEUTRALIZING ANTIBODY 17B 9606
772 3J70 2 B, N, S monoclonal antibody 17b heavy chain 9606
773 3CM9 3 L, M, N, O Ig alpha-2 chain C region 9606
774 3CHN 1 L, M, N, O Immunoglobulin kappa light chain 9606
775 2QTJ 1 L, M, N, O Kappa light chain IgA1 9606
776 2ESG 1 L, M Immunoglobulin A1 light chain 9606
777 1R70 1 A, C Human IgA2(m1) Light Chain 9606
778 1IGA 2 C, D IGA1 CHAINS A AND B, HEAVY, CHAINS C AND D, LIGHT 9606